MedCap
Research MedCap (MCAP.ST) on Bullrun: market cap SEK 7.81B, P/E 32.6. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMCAP.ST
- ExchangeXSTO
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Market capSEK 7.81B
- P/E32.6
- Financial periodQ2 2026
- RevenueSEK 606.30M
- Net incomeSEK 69.10M
- Free cash flowSEK 107.70M
- Gross margin59.8%
Valuation Snapshot
latest market cap is SEK 7.81B; P/E is 32.6.
Peer valuation comparison
Latest P/E is 32.59x versus a Healthcare sector median of 21.69x (50.3% above).
Latest P/E is 32.59x versus a Sweden median of 17.94x (81.6% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | SEK 1.81B | SEK 209.20M | SEK 318.30M | n/a | 14 | SEK 370.10M | SEK 358.00M | SEK 1.28B |
| FY2023 | SEK 1.59B | SEK 172.50M | SEK 205.90M | n/a | 11.6 | SEK 188.20M | n/a | SEK 1.02B |
| FY2022 | SEK 1.11B | SEK 118.00M | SEK 59.20M | n/a | 7.9 | SEK 236.20M | n/a | SEK 858.70M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-06 | SEK 7.81B | 32.6 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About MedCap
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MedCap's market cap?
MedCap's market capitalization is SEK 7.81B.
What is MedCap's P/E ratio?
MedCap's price-to-earnings (P/E) ratio is 32.6.
What does MedCap do?
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orthotics.